Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 808 results for "michael pearson"

What's Behind Valeant Pharmaceuticals Soaring 10% Today?
Motley Fool

Ex-Valeant CEO might have earned a $2.66B stock payoff. Today?...

Valeant Pharmaceuticals'now-ex CEO Michael Pearson could have been a billionaire more than four times over if his winning streak hadn't come to an ignominious end. Nowbowing out with apologies and mea culpas, Pearson racked up an apparent$140 ... FiercePharma, 4 hours ago
Contract Pharma

Lawmakers Blast Valeant for Price-Gouging Tactics

From left, Valeant's outgoing CEO, J. Michael Pearson; former chief financial officer Howard Schiller; and billionaire investor William Ackman, whose hedge fund holds a large stake in Valeant and controls two seats on its board of directors, are ...
 Continuity Insights3 days ago VALEANT PHARMACEUTICALS INTL : shares soar as new boss bids to save Canadian drug maker  4 Traders2 days ago Valeant Names Chairman, CEO  Contract Pharma3 days ago Valeant Pharmaceuticals Intl Inc (VRX) Calls Hot as Papa Swears In  Schaeffers Research3 days ago

Morning Read: Warren Buffett calls Valeant enormously flawed, Hollywood discovers science star

TOP STORIES Outgoing Valeant Pharmaceuticals International CEO Michael Pearson was a key force behind the steep price hikes that got Pearson on the congressional hot seat last week. This comes from documents Senate investigators collected over ...
 MedCity News4 days ago Valeant's annual report is finally out  Business Insider India1 week ago Valeant boss 'regrets' raising prices  BBC1 week ago Wall Street dropped a bomb on Valeant right before its Senate hearing  Yahoo! Finance UK and Ireland1 week ago
Yahoo! Finance UK and Ireland

Everyone going after Valeant is going after the same thing

Reuters Outgoing Valeant CEO, Michael Pearson All at once, everyone wants to know more about the mysterious programs that Valeant Pharmaceuticals uses to help people buy its drugs - patient assistance programs. The programs were mentioned in ...
 Business Insider India1 week ago A murky part of Valeant's business has suddenly caught everyone's attention — and the company can't be happy about it  Yahoo! Finance1 week ago

Warren Buffett: Don't run a company like Michael Pearson ran Valeant

Adam Jeffery | CNBC Warren Buffett There are many ways to run a business, but don't run one like Valeant Pharmaceuticals under Michael Pearson's tenure, legendary investor Warren Buffett said Monday. "I don't think you'd want your son to ...
 CNBC4 days ago

Valeant gutted its board less than 24 hours ago and already has some new nominees to refill it

(Reuters) Michael Pearson, Valeant CEO Valeant Pharmaceuticals stock was halted Friday morning ahead of announcing five nominees for election to its Board of Directors at the 2016 Annual Meeting of Shareholders on June 14 , 2016. The company ...
 Yahoo! India1 week ago Valeant is gutting its own board  Yahoo! Finance UK and Ireland1 week ago VALEANTS STOCK HALTED week ago

BRIEF-Valeant says Michael Pearson 2015 total compensation $143.1 mln

April 29 Valeant Pharmaceuticals International Inc * J. Michael Pearson 2015 total compensation of $143.1 million versus $10.4 million in 2014 * Says CFO Robert L. Rosiello FY 2015 total compensation $60.4 million - SEC filing * Group ...
 Reuters UK1 week ago Why Valeant Pharmaceuticals International's new CEO may signal a shift from disruptor to plain vanilla  McGill University1 week ago Valeant CEO will admit mistakes in jacking up drug prices  New York Post1 week ago Michael Pearson, Valeant's Outgoing CEO Admits Dramatic Increases of Certain Drugs was a Mistake  TopNews United States1 week ago
Business Insider

The Senate Hearing on Valeant in 3 Minutes

Pershing Square Capital Management CEO Bill Ackman, Valeant CEO Michael Pearson and former Interim Valeant CEO Howard Schiller testify on drug pricing before the Senate Special Committee on Aging.
 Bloomberg1 week ago LIVE: Bill Ackman and Valeant execs get grilled by angry Senators  Business Insider1 week ago
ACQ Magazine

Valeant CEO on Drug Price Hikes: We Made Mistakes

Valeant CEO Michael Pearson testified at a Senate hearing investigating drug pricing Wednesday that he and the company made mistakes and "Valeant was too aggressive." Watch an excerpt of his
 Herald Sun1 week ago GSK CEO: Big pharma should keep investing in R&D  Yahoo! Finance3 days ago Valeant Chief, at Senate Hearing, Concedes Mistakes on Steep Drug Prices  ACQ Magazine1 week ago Valeant Chief Says It Made Mistakes on Aggressive Drug Pricing  ACQ Magazine1 week ago
Business Insider

The disastrous Valeant document everyone's been waiting for is finally here

By 41 minutes ago (Reuters) Michael Pearson, former Valeant CEO After months of delays, a Senate hearing, and a precipitous stock fall, Valeant Pharmaceuticals finally filedtheir annual 10-k report to the SEC Friday ...
 Yahoo! Finance1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - michael pearson
Get updated on latest news & your favorite topics right in your inbox!
More     Less